[中国住院心力衰竭患者当前状况调查,2023-2024年]
1Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua xin xue guan bing za zhi
|February 13, 2026
概括
心脏衰竭与保存的喷射分数 (HFpEF) 在中国最常见,冠状动脉心脏病普遍存在. 虽然HFrEF患者接受指导方针导向的医学治疗,但HFpEF治疗和设备治疗需要优化.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是中国的一个重大公共卫生问题.
- 了解住院HF患者的特征对于改善护理至关重要.
- 需要最新的关于HF亚型,病因和治疗模式的数据.
研究的目的:
- 研究中国住院心力衰竭患者的临床状况,病因因素,并发症和治疗策略.
- 分析心力衰竭亚型之间的特征和治疗的差异:减少喷射率 (HFrEF),轻度减少喷射率 (HFmrEF) 和保存喷射率 (HFpEF).
主要方法:
- 一项采用中国心力衰竭登记 (2023-2024) 数据的横截面研究.
- 招募了250,936名住院HF患者,根据左心室喷射分数分类为HFrEF,HFmrEF和HFpEF.
- 通过基于网络的系统收集了包括人口统计,病因学,并发症和治疗策略在内的综合性临床数据.
主要成果:
- 在住院的HF患者中,HFpEF占最大比例 (43.83%).
- 冠心病是最常见的病因 (62.18%),导致因素 (49.36%),并发病 (65.95%).
- 在HFrEF患者中观察到指导方针导向医疗疗的高利用率,但设备治疗的利用率不足. 在HFpEF中使用-葡萄糖共运输体2抑制剂和并发症管理需要改进.
结论:
- 在中国,HFpEF是住院HF患者中占主导地位的亚型.
- 冠心病显著影响HF病因,住院触发因素和并发症.
- 优化治疗,包括药物和设备治疗,特别是HFpEF,对于改善中国HF患者的治疗结果至关重要.
更多相关视频
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.2K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
666
相关概念视频
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Surveys
17.1K
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
17.1K
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
966
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Hospitals-II
1.2K
Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
Nurses that work in...
1.2K
Heart Failure VI: Adjunct Therapies
402
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
